A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...

Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...

Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The mRNA Therapeutics market is expanding due to advancements in drug development, personalized medicine, and delivery technologies. Opportunities arise from the technology's success in vaccines and ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

Return on Equity (ROE): Arcturus Therapeutics's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -5.93%, the company showcases ...

Secretary Robert F. Kennedy Jr. said his department would slash funding for mRNA vaccine research and shift its focus to ...

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...